New Two-Drug combo challenges standard lymphoma treatment
Disease control
Recruiting now
This study is testing whether a new combination of two targeted drugs (linperlisib and chidamide) works better and is safer than the standard CHOP chemotherapy for people newly diagnosed with peripheral T-cell lymphoma (PTCL). The trial has two main parts: first finding the best …
Phase: PHASE1, PHASE2 • Sponsor: Yanyan Liu • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC